Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma
Clinical trial NCT05187884 · COMPLETED
Trial details
- NCT number
- NCT05187884
- Sponsor
- St Vincent's Hospital, Sydney
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2025-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.